This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Mechanisms and Risks of Electrocardiographic QT Interval Prolongation When Using Antipsychotic Drugs

W. Victor R. Vieweg, MD

Published: September 1, 2002

Article Abstract

This article reviews cardiac electrophysiology, with a focus on the assessment of the electrocardiographicallydetermined corrected QT (QTc) interval and its role as a marker for potentially lifethreateningcardiac arrhythmias such as torsades de pointes. Presently, using the QTc interval as a surrogatefor polymorphic ventricular tachycardia is handicapped, in part, by the limitations of currentlyavailable group-derived formulas to estimate the QTc interval. Regulatory agencies have sharpenedtheir interest in this arena. Substantial progress almost certainly awaits the application of individualrather than group-derived formulas to estimate the QTc interval. Until this refinement arrives, cliniciansare advised to exercise caution when administering antipsychotic drugs with the potential tosignificantly prolong the QT interval. Caution is particularly urged in patients with cardiovasculardisease or risk factors for cardiovascular disease.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...